Article info

Download PDFPDF
Intraocular methotrexate for epithelial downgrowth: long-term outcomes in a multicentre case series

Authors

  1. Correspondence to Dr Marie Eve Légaré, Department of Ophthalmology, Centre Hospitalier affilié Universitaire de Québec Hôpital du Saint-Sacrement, Quebec, Canada; marie-eve.legare{at}fmed.ulaval.ca
View Full Text

Citation

Hébert M, Kyrillos R, Snyder ME, et al
Intraocular methotrexate for epithelial downgrowth: long-term outcomes in a multicentre case series

Publication history

  • Received January 28, 2022
  • Accepted May 15, 2022
  • First published June 1, 2022.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.